Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PIII
stocks logo

PIII

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
356.52M
-5.97%
--
--
344.51M
-4.86%
--
--
353.03M
-4.76%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for P3 Health Partners Inc. (PIII) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -40.15%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-40.15%
In Past 3 Month
Wall Street analysts forecast PIII stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PIII is 14.00 USD with a low forecast of 8.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast PIII stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PIII is 14.00 USD with a low forecast of 8.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 5.251
sliders
Low
8.00
Averages
14.00
High
20.00
Current: 5.251
sliders
Low
8.00
Averages
14.00
High
20.00
Lake Street
Buy
downgrade
$20
2025-11-17
Reason
Lake Street
Price Target
$20
2025-11-17
downgrade
Buy
Reason
Lake Street lowered the firm's price target on P3 Health Partners to $12.50 from $20 and keeps a Buy rating on the shares. Though Q3 aEBITDA results were "disappointing," P3 is "making progress, even if it is not yet evident in reported results," which should point to a much-improved 2026, the analyst tells investors.
Lake Street
NULL
to
Buy
initiated
$20
2025-08-28
Reason
Lake Street
Price Target
$20
2025-08-28
initiated
NULL
to
Buy
Reason
Lake Street assumed coverage of P3 Health Partners with a Buy rating and $20 price target. Despite first half revenue declining versus the prior year, Q2 results showed "encouraging signs," the analyst tells investors. 2025 remains a transitional year as the P3 sets up for a "transformational 2026," the analyst added.
TD Cowen
Hold
downgrade
$8
2025-05-28
Reason
TD Cowen
Price Target
$8
2025-05-28
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on P3 Health Partners to $8 from $12.50 and keeps a Hold rating on the shares. The firm updated its model to reflect Q1 results and adjusted its $o.50 target to reflect the company's 1-for-50 reverse stock split.
Lake Street
Brooks O'Neil
Strong Buy
Maintains
$50 → $20
2025-04-21
Reason
Lake Street
Brooks O'Neil
Price Target
$50 → $20
2025-04-21
Maintains
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for P3 Health Partners Inc (PIII.O) is -0.56, compared to its 5-year average forward P/E of -5.97. For a more detailed relative valuation and DCF analysis to assess P3 Health Partners Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-5.97
Current PE
-0.56
Overvalued PE
3.23
Undervalued PE
-15.18

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.49
Current EV/EBITDA
-6.28
Overvalued EV/EBITDA
83.91
Undervalued EV/EBITDA
-88.88

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
0.19
Current PS
0.01
Overvalued PS
0.36
Undervalued PS
0.01
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

PIII News & Events

Events Timeline

(ET)
2025-11-13
17:36:13
P3 Health Partners Adjusts FY25 Revenue Forecast to $1.40-$1.45B, Up from $1.35B-$1.5B
select
2025-11-13
17:34:30
P3 Health Partners Announces Q3 Earnings Per Share of $9.67, Exceeding Consensus Estimate of $6.04
select
2025-08-14 (ET)
2025-08-14
16:16:02
P3 Health Partners sees FY25 revenue $1.35B-$1.5B, consensus $1.43B
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
12-03Newsfilter
P3 Health Partners Forms Joint Venture with Commonwealth to Expand Value-Based Care
  • Joint Venture Formation: P3 Health Partners and Commonwealth Primary Care ACO have established a Joint Venture Management Services Organization aimed at expanding value-based care support across Arizona, California, Nevada, Oregon, and North Carolina, enhancing service capabilities for primary care physicians.
  • Market Expansion: This partnership expands P3's footprint into Maricopa County, Arizona, further solidifying its position in a key growth market, which is expected to drive business growth in the region.
  • Operational Efficiency Improvement: The joint venture combines P3's strengths in Medicare Advantage and ACO with Commonwealth's ACO REACH program to create a unified operational platform, thereby enhancing performance and efficiency in healthcare delivery.
  • Physician Support Enhancement: The joint venture will strengthen support for independent primary care physicians by sharing operations and best practices, ensuring they can thrive and deliver exceptional care in a value-based environment.
[object Object]
Preview
6.5
11-04NASDAQ.COM
Projected Target Price for ONEQ Analyst: $104

  • ETF Performance Analysis: The Fidelity Nasdaq Composite Index ETF (ONEQ) has an implied analyst target price of $103.84, indicating a potential upside of 10.75% from its current trading price of $93.76.

  • Notable Holdings: Key underlying holdings with significant upside potential include KODIAK ROBOTICS INC (KDK), Red Cat Holdings Inc (RCAT), and P3 Health Partners Inc (PIII), with expected price increases of 96.58%, 62.44%, and 58.15% respectively.

  • Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they are based on outdated information.

  • Investor Research Recommendation: Investors are encouraged to conduct further research to assess the validity of analysts' targets in light of recent company and industry developments.

[object Object]
Preview
7.5
08-25Newsfilter
Catalyst Solutions Successfully Launches P3 Implementation in Four States

  • Successful Implementation: Catalyst Solutions has successfully launched the Professional Health Partners Services (P3) Implementation, which began in May 2025, enhancing services for Medicare members across multiple states.

  • Operational Support: The implementation supports eleven health plans and nearly 68,000 members in Arizona, Oregon, Nevada, and California, with additional support for a new Medicare plan on the way.

  • Partnership Recognition: Both Catalyst Solutions and P3 Health Partners express pride in their collaboration, highlighting the effective execution of the project within a tight 60-day timeframe.

  • Commitment to Improvement: Catalyst Solutions aims to drive value through agile implementations and operational expertise, focusing on improving health outcomes and cost efficiency for health plans.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is P3 Health Partners Inc (PIII) stock price today?

The current price of PIII is 5.2514 USD — it has decreased -6.57 % in the last trading day.

arrow icon

What is P3 Health Partners Inc (PIII)'s business?

P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.

arrow icon

What is the price predicton of PIII Stock?

Wall Street analysts forecast PIII stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PIII is 14.00 USD with a low forecast of 8.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is P3 Health Partners Inc (PIII)'s revenue for the last quarter?

P3 Health Partners Inc revenue for the last quarter amounts to 373.23M USD, decreased -3.93 % YoY.

arrow icon

What is P3 Health Partners Inc (PIII)'s earnings per share (EPS) for the last quarter?

P3 Health Partners Inc. EPS for the last quarter amounts to -314.11 USD, increased 3896.31 % YoY.

arrow icon

What changes have occurred in the market's expectations for P3 Health Partners Inc (PIII)'s fundamentals?

The market is revising No Change the revenue expectations for P3 Health Partners Inc. (PIII) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -40.15%.
arrow icon

How many employees does P3 Health Partners Inc (PIII). have?

P3 Health Partners Inc (PIII) has 360 emplpoyees as of December 05 2025.

arrow icon

What is P3 Health Partners Inc (PIII) market cap?

Today PIII has the market capitalization of 91.20M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free